Entering Korea? How FTO and Opinion Letters Can Help Reduce 5x Patent Damages Risk
Pine IP
March 24, 2026
For companies entering the Korean market, patent clearance is no longer a box-ticking exercise. It is a business-critical step. South Korea’s Patent Act allows courts to award up to five times the amount of recognized damages where patent infringement is found to be intentional. That 5x ceiling took effect on August 21, 2024, after the law was amended from the previous 3x standard.
That does not mean every infringement case will lead to enhanced damages. But it does mean this: if a company enters Korea without a serious patent risk review, and later faces an allegation that it knowingly proceeded despite the risk, the exposure can become significantly more severe. Under Article 128(9) of the Patent Act, Korean courts consider multiple factors when determining enhanced damages, including the infringer’s relative market position, degree of knowledge or awareness of likely harm, scale of harm to the patentee, economic benefit gained from the infringement, duration and frequency of the conduct, fines, financial status, and efforts to remedy the harm.
This is why a properly prepared freedom-to-operate (FTO) analysis and a well-reasoned opinion letter matter.
A Korea-focused FTO analysis helps a business answer a practical question before launch:
Can we make, import, offer, sell, or use this product in Korea without infringing a Korean patent?
That question sounds simple, but in practice it requires localized legal analysis. A U.S., European, or global patent review is often not enough. Korean patent rights are territorial. Claim scope, prosecution history, family status, term adjustments, licensing structure, and enforceability must all be reviewed in the Korean context.
For inbound companies, the biggest mistake is assuming that product clearance done for another jurisdiction will automatically cover Korea. It will not. A business may be non-infringing in one country and still face live patent risk in South Korea because the relevant patent family, claim language, or legal posture is different.
The careful answer is yes, potentially—but not automatically.
Korea’s Patent Act does not create a formal “safe harbor” saying that an opinion letter automatically defeats willful infringement. What the statute does say is that enhanced damages depend on whether infringement is found to be intentional, and courts must assess factors including the infringer’s awareness, economic gain, duration of conduct, and efforts to reduce or remedy harm. That framework strongly suggests that evidence of good-faith pre-launch review may help reduce allegations of reckless or intentional conduct, depending on the facts.
In other words, an opinion letter is not magic. A weak, generic, or post hoc memo is unlikely to help. But a timely, substantive, and Korea-specific legal opinion can become an important part of the record showing that the company did not simply ignore a known patent risk.
That is especially important when a company has:
In those situations, the real issue is not only whether infringement exists. The issue is also what the company knew, when it knew it, and what it did in response.
A useful opinion letter for Korean market entry should not read like a memo written only for optics. It should be prepared to support actual business decision-making.
At minimum, the analysis should consider:
The opinion should compare the target Korean patent claims against the actual product, process, or software workflow—not a marketing summary.
In some cases, the best answer is not only non-infringement, but also invalidity risk in the asserted patent.
A patent family may look broad at first glance, but file history, amendments, disclaimers, or related Korean family members may materially change the risk assessment.
The letter should address the actual planned conduct in Korea: importation, local sale, distributor channels, manufacturing, SaaS access, or platform operation.
A good opinion should not stop at “high risk” or “low risk.” It should help management choose among redesign, licensing, phased launch, supply-chain adjustments, or further invalidation review.
If the opinion is created after launch, after a cease-and-desist letter, or after litigation becomes imminent, its value may be limited. The better practice is to build the record before commercial entry, or at least immediately after a concrete patent issue is identified.
That timing matters because enhanced-damages analysis in Korea turns in part on the company’s state of mind and remedial conduct. The statute expressly tells courts to consider the infringer’s degree of awareness and efforts to reduce harm. A contemporaneous FTO and opinion process can therefore be more persuasive than a defensive memo created later.
Korea is a sophisticated patent enforcement market. Companies entering Korea through exports, online sales, distributors, OEM relationships, or direct local commercialization should assume that patent risk needs to be assessed locally—not by copy-pasting a foreign clearance memo.
A Korea-ready FTO strategy should align legal analysis with business execution. That means legal teams, business teams, and technical teams should all understand:
If your company is planning to enter South Korea, do not wait for a demand letter to think about FTO.
Under Korean law, intentional patent infringement can expose a company to up to 5x damages, and courts are directed to look at knowledge, gains, duration, and remedial efforts when assessing enhanced damages. That makes pre-entry diligence far more than a technical exercise. It is part of building a defensible business record.
A well-prepared Korea FTO analysis and opinion letter will not guarantee immunity. But they can play a meaningful role in reducing willfulness exposure, supporting good-faith decision-making, and helping management enter the Korean market with greater confidence.
Pine IP Firm helps global businesses assess Korean patent risk before launch, prepare Korea-focused FTO analyses, and develop opinion letters that are practical, defensible, and tailored to real market-entry decisions.
